could I get a script that can generate some basic statistics from the velvet output file (contigs.fa)
Unconfigured Ad
Collapse
X
-
Thanks. to be more specific I would like to see the following statistics for velvet output fasta file:
-Statistics for contig lengths:
Min contig length
Max contig length
Mean contig length
standard deviation of contig length
Median contig length
N50 contig length
- Statistics for no. of contigs:
No. of contigs
No of contigs >=1kb
No. of contigs in N50
-Statistics for bases in the contigs:
No. of bases in all contigs
No. of bases in contigs >=1kb
GC content of contigs
-Simple Dinucleotide repeats:
No. of contigs with over 70% dinucleotide repeats
AT
CG
AC
TG
AG
TC
_Simple mononucleotide repeats:
No. of contigs with over 50% dinucleotide repeats
AA
TT
CC
GG
Comment
-
i don't which of your interest will be covered but have a look here velet std summary. I find the way they do it quite neat. However, i think you have to script something yourself to get all desired information.
Comment
-
Using Biopieces (www.biopieces.org):
Assembled contigs can be analyzed to get some stats using analyze_assembly. We include a filtering step to discard contigs shorter than 200 bases:
And the output:Code:read_fasta -i contigs.fna | grab -e "SEQ_LEN>=200" | analyze_assembly -x
There are many other options for stats as well. Look here:Code:N50: 9082 MAX: 52038 MIN: 200 MEAN: 4170 TOTAL: 3057214 COUNT: 733 ---
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
43 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment